Doorgaan naar hoofdcontent

Metalyse - opinion on variation to marketing authorisation | European Medicines Agency (EMA)

Metalyse - opinion on variation to marketing authorisation | European Medicines Agency (EMA)

On 14 December 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Metalyse. The marketing authorisation holder for thi

Lees verder »
Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief